Positivity Rate of Person under Surveillance among Institut Jantung Negara’s Patients with Various COVID-19 Vaccination Status in the First Quarter of 2022, Malaysia

Authors: M. Izzat Md. Nor, N. Jaffar, N. Zaitulakma Md. Zain, N. Izyanti Mohd Suppian, S. Balakrishnan, G. Kandavello

Abstract:

During the Coronavirus (COVID-19) pandemic, Malaysia has been focusing on building herd immunity by introducing vaccination programs into the community. Hospital Standard Operating Procedures (SOP) were developed to prevent inpatient transmission. In this study, we focus on the positivity rate of inpatient Person Under Surveillance (PUS) becoming COVID-19 positive and compare this to the national rate in order to see the outcomes of the patient who becomes COVID-19 positive in relation to their vaccination status. This is a retrospective observational study carried out from 1 January until 30 March 2022 in Institut Jantung Negara (IJN). There were 5,255 patients admitted during the time of this study. Pre-admission Polymerase Chain Reaction (PCR) swab was done for all patients. Patients with positive PCR on pre-admission screening were excluded. The patients who had exposure to COVID-19-positive staff or patients during hospitalization were defined as PUS and were quarantined and monitored for potential COVID-19 infection. Their frequency and risk of exposure (WHO definition) were recorded. On the final day of quarantine, a second PCR swab was performed on PUS patients who exhibit clinical deterioration, whether or not they exhibit COVID-19 symptoms. The severity of COVID-19 infection was defined as category 1-5A. All patients' vaccination status was recorded, and they were divided into three groups: fully immunised, partially immunised, and unvaccinated. We analysed the positivity rate of PUS patients becoming COVID-positive, outcomes, and correlation with the vaccination status. The ratio of positive inpatient PUS to the total inpatient PUS is 492; only 13 became positive, giving a positivity rate of 2.6%. Eight (62%) had multiple exposures. The majority, 8/13(72.7%), had a high-risk exposure, and the remaining 5 had medium-risk exposure. Four (30.8%) were boosted, 7(53.8%) were fully vaccinated, and 2(15.4%) were partial/unvaccinated. Eight patients were in categories 1-2, whilst 38% were in categories 3-5. Vaccination status did not correlate with COVID-19 Category (P = 0.641). One (7.7%) patient died due to COVID-19 complications and sepsis. Within the first quarter of 2022, our institution's positivity rate (2.6%) is significantly lower than the country's (14.4%). High-risk exposure and multiple exposures to positive COVID-19 cases increased the risk of PUS becoming COVID-19 positive despite their underlying vaccination status.

Keywords: COVID-19, boosted, high risk, Malaysia, quarantine, vaccination status.

References:

[1] Ministry of Health Malaysia, 2022, "Fasa Peralihan ke Endemik", https://covid-19.moh.gov.my/reopeningsafely/semasa/2022/03/fasa-peralihan-ke-endemik-11032022 (April 1, 2022).
[2] R. Hirschmann, 2022, "Vaccination rate against COVID-19 Malaysia 2022, by state", https://www.statista.com/statistics/1270638/malaysia-covid-19-vaccination-rate-by-state/ (Mar 31, 2022).
[3] Ministry of Health Malaysia, 2021, COVID-19 immunisation task force, "Malaysia positivity rate", https://covidnow.moh.gov.my/ (March 31, 2021).
[4] Director General of Health Malaysia, Surat Pekeliling Ketua Pengarah Kesihatan Bil. 4/2021, "Polisi Pelaksanaan program imunisasi COVID-19 Kebangsaan', pp 1-5 (march 3, 2021).
[5] World Health Organization WHO, 2020, COVID-19: Infection prevention and control, "Risk assessment and management of exposure of health care workers in the context of COVID-19: interim guidance", https://www.who.int/publications/i/item/WHO-2019-nCov-HCW_risk_assessment-2020.2 (March 19,2020).
[6] World Health Organization (WHO), 2022, Clinical management of COVID-19 patents: living guideline, PP 28-30
[7] Ministry of Health Malaysia,2022, Annex 2e Clinical Management of Confirmed COVID-19 Case in Adult And Paediatric,
[8] National Institutes of Health, 2022, "Clinical Spectrum of SARS-CoV-2 Infection", https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/ (September 26,2022).
[9] Ministry of health Malaysia, 2022, Annex 21, "Management of Healthcare Workers (HCW) during the COVID-19 Pandemic " pp 10-13 (Feb 15, 2022).